Atea Pharmaceuticals Inc (AVIR)

Income Tax Expense

-$6.50M

TTM · Period ending: · USD

AVIR logo

AVIR Income Tax Expense

Latest reported-$6.50M
AVIR TTM Income Tax ($0.00 → -$6.50M)
High-resolution chart · PNG

AVIR income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
-6,498,000
-6,315,000
-6,162,000
831,000
861,000
897,000
925,000
1,049,000
1,044,000
1,052,000
1,018,000
792,000
-3,262,000
-3,393,000
-3,590,000
387,000
10,320,000
17,400,000
17,400,000
13,300,000
7,200,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.